Searched for
PFIZER NEWS
In the shadow of COVID, health officials fight panic over Hantavirus outbreakA hantavirus outbreak on a cruise ship has sparked public concern. Health officials are working to communicate clearly, drawing lessons fro...- Why US stock market Dow Jones, S&P 500 and Nasdaq are surging big today: Dow jumps 350 points, Nasdaq jumps 250 points as Intel hits all-time high driving the rallyUS stock market surges today: why Dow Jones, S&P 500, and Nasdaq are rallying sharply despite global tensions? The Dow Jones Industrial Ave...
- US stock market today: Why is Nasdaq crashing big today? Dow and S&P 500 slip as Nasdaq plunges over 300 points - Nvidia, AMD, Intel lead tech lossesUS stock market today: Nasdaq crashing big today as Dow Jones and S&P 500 also slip. The US stock market today shows a sharp shift. The Nas...
- US Stocks | Kailera soars over 60% in Nasdaq debut as weight-loss drug race heats upKailera Therapeutics shares surged 62.5% in their Nasdaq debut after raising $625 million in a U.S. IPO priced at the top end of its range....
- Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...
- Trump administration readies new tariffs on select drugmakers: ReportThe Trump administration is reportedly preparing to impose 100% tariffs on drugmakers that haven't secured deals for lower U.S. prices. Sev...
- Pfizer to acquire obesity drug startup Metsera in $10 billion dealPfizer has agreed to acquire obesity drug developer Metsera for up to $86.25 a share, surpassing Novo Nordisk's final offer. This move mark...
- AstraZeneca gets $107 mln Pfizer verdict overturned in US cancer drug patent fightOn Wednesday, U.S. District Judge Matthew Kennelly invalidated Pfizer’s patents related to the cancer drug Nerlynx, overturning a jury's $1...
- Pfizer offers to sell medicines at cost to world's poorest countries"An Accord for a Healthier World" focuses on five areas: infectious diseases, cancer, inflammation, rare diseases and women's health -- whe...
- Covid pills cannot do the job alone; disease experts say there's no substitute for vaccinesThe antiviral medications stop the virus from replicating in the body.
- Pfizer rallies 8% on strong Q2 show, new Covid pillThe US multinational pharmaceutical and biotechnology firm further announced that its experimental antiviral pill to treat COVID-19 can cut...
- Pfizer booster shot may start in US by September 20: Anthony FauciThe rollout for Moderna's booster vaccine could, however, be delayed, CNBC news quoted Anthony Fauci as saying on Sunday. Although both dru...
- European Union set to seek clarification from Pfizer over fresh coronavirus vaccine delaysPfizer and the Commission had earlier said that there would be no more slowdowns next week, after supplies were held up this week due to wo...
- Pfizer delays January vaccine delivery to Bahrain: Health MinistryA January shipment of the Pfizer-BioNTech vaccine to the Gulf state of Bahrain will not arrive on time, the ministry of health said on Satu...
- Pfizer applies for COVID-19 vaccine approval in JapanDrugmaker Pfizer Inc said on Friday it had applied for approval in Japan for its COVID-19 vaccine, which is already being administered in t...
- First shipments of Pfizer vaccine leave Michigan manufacturing facilityThe first trucks carrying the vaccine for widespread use in the US pulled out of a Pfitzer manufacturing plant in Michigan on Sunday, en ro...
- Bahrain approves Chinese COVID-19 vaccine for useThe Sinopharm vaccine has been approved for emergency use in a few countries and the company is still conducting late-stage clinical trials...
- Pfizer Q1 net profit down 28.57 per cent to Rs 57.17 crPfizer's total income was at Rs 459.86 crore as against Rs 542.41 crore in the year-ago period, down 15.21 per cent.
- Pfizer rallies 18% intraday, closes day 9% higher on parent's restructuring bidThe company said that a unit of its parent Pfizer Inc will buy about 61 per cent stake from two other units after an internal restructuring.
- Ranbaxy and Pfizer sued for delay in launch of Lipitor in USA group of US pharmacies filed lawsuit against Ranbaxy, Pfizer & accused the two drug firms of delaying the launch of Lipitor in the US
Load More
